Latest Conference

Milena McLaughlin, PharmD, MSc, explains different strategies institutions can take to obtain antimicrobials that are on shortage.

Arjun Srinivasan, MD, stresses the importance of making outbreak investigations a team effort.

Jason Pogue, PharmD, BCPS-ID, explains the limitations of the current drugs for the treatment of Pseudomonas aeruginosa infections.

Caetano Sabino, BSc, explains how photodynamic therapy can be used to challenge microbial resistance of localized infections.

Conan MacDougall, PharmD, explains what individuals should consider when it comes to adopting interventions in antibiotic stewardship programs.

Otto Schwake, PhD, discusses how he and his team sought to validate their hypothesis regarding climate and Legionella presence in car washer fluid.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how the role of antimicrobial susceptibility tests can be undermined by delays between approval of new antibiotics and the tests that will optimize their use.

Milena McLaughlin, PharmD, MSc, explains the key points that should be incorporated into institutional plans for dealing with antimicrobial shortages.

Snigdha Vallabhaneni, MD, MPH, discusses the drugs available to treat Candida infections.

Kenneth Mayer, MD, discusses the current challenges of improving pre-exposure prophylaxis delivery and adherence in the United States.

Meghan Jeffres, PharmD, explains what practitioners should keep in mind when prescribing beta-lactams.

Otto Schwake, PhD, explains how likely it is for someone to catch Legionnaire’s disease from windshield washer fluid.

Snigdha Vallabhaneni, MD, MPH, discusses the incidence of Candida auris in the United States.

Conan MacDougall, PharmD, discusses some interventions that have been shown to produce negative behavioral changes for antibiotic stewardship.

Belinda Ostrowsky, MD, MPH, explains how to treat patients who expect to receive an antibiotic, but should not.

Kirk Hevener, PharmD, PhD, explains why narrow-spectrum antibiotics are more beneficial for treating C. difficile.

Milena McLaughlin, PharmD, MSc, explains strategies institutions can take to address antimicrobial shortages.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing for off-label indications.

Genovefa Papanicolaou, MD, discusses a new antiviral in development to prevent cytomegalovirus.

Arjun Srinivasan, MD, discusses the "steps" associated with investigating an outbreak.

Otto Schwake, PhD, postulates how Legionella might get into automobile windshield washer fluid and if there is any way to prevent it.

Milena McLaughlin, PharmD, MSc, explains the different ways that antimicrobial shortages can impact patient care.

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains which studies are ideal to run through a meta-analysis.

Lauri A. Hicks, DO, discusses the use of immunotherapy in tackling antibiotic resistance.

Nicola Thompson, PhD, shares what is needed to estimate the burden of healthcare-associated infections in nursing homes.

Snigdha Vallabhaneni, MD, MPH, discusses the keys to controlling the spread of Candida auris.

Lillian Abbo, MD, shares key elements that clinicians should incorporate into antimicrobial stewardship practices.

Jeremy Burrows, DPhil, MA, explains how new antimalarials could change the game for countries where malaria is endemic.